GREENSBORO, NC — (July 31, 2024) — Carolina Liquid Chemistries Corp. (CLC) has entered into a distribution agreement with Medline Industries, LP (Medline) to make the first ever FDA-cleared, point-of-care fentanyl screening test kit readily available to many point-of-care sites and clinical laboratories across the United States of America. Medline, a medical supply manufacturer, distributor, and solutions provider, has 38,000+ employees worldwide to serve healthcare providers across the continuum of care.

“This is a great opportunity for Medline to be part of the solution to the drug crisis in America,” says Nicole Krpan, Medline Laboratories Division General Manager. “The opioid epidemic, exacerbated by the potency of fentanyl, claims countless lives every day. With its low cutoff and rapid results, this test offers a new weapon in the fight against the effects of fentanyl.”

The test kit, called Fentanyl Urine Detect, is intended for the qualitative detection of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL with a result in under six minutes. The test is used in conjunction with Carolina Liquid Chemistries’ RYAN immunofluorescence analyzer and can produce a printed, chartable result that is interfaceable with laboratory information systems (LIS). The test provides a preliminary result; a more specific alternative chemical method must be used in order to obtain a confirmed analytical result.

Philip Shugart, CEO of Carolina Liquid Chemistries, says, “The RYAN is easy to use and produces a printable, objective result which avoids the subjectivity associated with human interpretation.” Mr. Shugart adds, “It’s great to get a chartable result in only six minutes.”

The RYAN analyzer is a fluorescence instrument for in vitro diagnostic tests on clinical urine specimens. Weighing less than five pounds, this portable analyzer can be used in a laboratory or in a point-of-care setting. To learn more about Fentanyl Urine Detect on the immunofluorescence analyzer RYAN, please visit https://www.carolinachemistries.com/products/fentanyl-urine-detect-on-clc-ryan-analyzer/

About Carolina Liquid Chemistries Corp.

Carolina Liquid Chemistries Corp. (CLC) is a certified Veteran-Owned Business headquartered in Greensboro, NC with its reagent production facility in Brea, CA. CLC is an ISO 13485: 2016 certified and FDA-registered manufacturer, re-packager, re-labeler, and value-added reseller of clinical chemistry instruments and reagents for general chemistries and urine drug screening assays along with hematology and immunoassay analyzers. For more information, call 877-722-8910 x103, visit www.carolinachemistries.com, or email [email protected].

About Medline Industries, LP
Medline is a healthcare company — a medical supply manufacturer, distributor, and solutions provider focused on improving the overall operating performance of healthcare. Partnering across the continuum of care, Medline helps providers to activate the clinical and supply chain resources needed to deliver their best care. With the agility to solve problems quickly and the scale to partner with providers for their sustained success, Medline is able to invest in its customers for the future and rapidly respond to a dynamically changing market with customized solutions. Headquartered in Northfield, Ill., Medline has 38,000+ employees worldwide and operates in over 100 countries and territories. Learn more at www.medline.com.